These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12114329)

  • 21. Comment: treatment of heparin-induced thrombocytopenia.
    Smythe MA; Warkentin TE
    Ann Pharmacother; 2002 Sep; 36(9):1483-4; author reply 1484. PubMed ID: 12196076
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of an acute flush reaction caused by subcutaneous r-hirudin with pegylated hirudin.
    Harenberg J; Hoffmann U; Huhle G; Song XH; Wang LC
    Br J Haematol; 2000 Mar; 108(3):528-30. PubMed ID: 10759710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
    Chamberlin JR; Lewis B; Leya F; Wallis D; Messmore H; Hoppensteadt D; Walenga JM; Moran S; Fareed J; McKiernan T
    Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
    Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
    Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of heparin-induced thrombocytopenia.
    Dager WE; White RH
    Ann Pharmacother; 2002 Mar; 36(3):489-503. PubMed ID: 11895064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hirulog therapy for heparin-associated thrombocytopenia and deep venous thrombosis.
    Reid T; Alving BM
    Am J Hematol; 1994 Apr; 45(4):352-3. PubMed ID: 8192819
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
    Fabrizio MC
    J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report.
    Whelen S; Carr ME
    Angiology; 2001 Oct; 52(10):711-5. PubMed ID: 11666136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lepirudin anticoagulation for heparin-induced thrombocytopenia.
    Deitcher SR; Topoulos AP; Bartholomew JR; Kichuk-Chrisant MR
    J Pediatr; 2002 Feb; 140(2):264-6. PubMed ID: 11865285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In AT-III deficiency: heparin or hirudin?].
    Spannagel U
    MMW Fortschr Med; 1999 Oct; 141(42):14. PubMed ID: 10912097
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heparin-induced thrombocytopenia type II. Intra- and postoperative lepirudin treatment in acute ischemia of the extremities].
    Schmidt O; Lang W
    Dtsch Med Wochenschr; 1998 Oct; 123(41):1207-10. PubMed ID: 9810286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
    Dager WE; White RH
    Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-induced thrombocytopenia: a review of current pharmacologic treatment.
    Talati R; Colemen CI; White CM
    Conn Med; 2008 May; 72(5):275-9. PubMed ID: 18593063
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anticoagulation after venous thrombosis caused by type-II HIT syndrome].
    Janssens U
    Dtsch Med Wochenschr; 1998 Apr; 123(14):438-9. PubMed ID: 9581173
    [No Abstract]   [Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIT, HITT, and desulfatohirudin: look before you leap.
    Edmunds LH
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):1-3. PubMed ID: 7609532
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia and cardiovascular patients: recognition and treatment.
    Baker KM; Flattery MP
    Prog Cardiovasc Nurs; 2006; 21(1):47-50. PubMed ID: 16522970
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of heparin-induced thrombocytopenia: a critical review.
    Hirsh J; Heddle N; Kelton JG
    Arch Intern Med; 2004 Feb; 164(4):361-9. PubMed ID: 14980986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study].
    Huhle G; Hoffmann U; Hoffmann I; Harenberg J; Heene DL
    Dtsch Med Wochenschr; 2000 Jun; 125(22):686-91. PubMed ID: 10874895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.